RT Journal Article
SR Electronic
T1 Genomic surveillance of SARS-CoV-2 in a university community: insights into tracking variants, transmission, and spread of Gamma (P.1) variant
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.02.25.22271521
DO 10.1101/2022.02.25.22271521
A1 Ilinca I. Ciubotariu
A1 Jack Dorman
A1 Nicole M. Perry
A1 Lev Gorenstein
A1 Jobin J. Kattoor
A1 Abebe A. Fola
A1 Amy Zine
A1 G. Kenitra Hendrix
A1 Rebecca P. Wilkes
A1 Andrew Kitchen
A1 Giovanna Carpi
YR 2022
UL http://medrxiv.org/content/early/2022/02/28/2022.02.25.22271521.abstract
AB Using a combination of data from routine surveillance, genomic sequencing, and phylogeographic analysis we tracked the spread and introduction events of SARS-CoV-2 variants focusing on a large university community. Here, we sequenced and analyzed 677 high-quality SARS-CoV-2 genomes from positive RNA samples collected from Purdue University students, faculty, and staff who tested positive for the virus between January 2021 and May 2021, comprising an average of 32% of weekly cases across the time frame. Our analysis of circulating SARS-CoV-2 variants over time revealed periods when Variant of Concern (VOC) Alpha (B.1.1.7) and Iota (B.1.526) reached rapid dominance and documented that VOC Gamma (P.1) was increasing in frequency as campus surveillance was ending. Phylodynamic analysis of Gamma genomes from campus alongside a subsampling of >20,000 previously published P.1 genomes revealed ten independent introductions of this variant into the Purdue community, predominantly from elsewhere in the United States, with introductions from within the state of Indiana and from Illinois, and possibly Washington and New York, suggesting a degree of domestic spread. We conclude that a robust and sustained active and passive surveillance program coupled with genomic sequencing during a pandemic offers important insights into the dynamics of pathogen arrival and spread in a campus community and can help guide mitigation measures.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by funds to G.C. from the Purdue Department of Biological Sciences and partially by the Protect Purdue funds to G.C.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board from the Purdue University Human Research Protection Program determined that viral genome sequencing of de-identified remnant COVID-19 samples included in this study is not research involving human subjects (IRB-2021-438).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll of the genomic data generated from our lab used in this research is available on GISAID (see table S3 for accession numbers). We also gratefully acknowledge the authors and submitting laboratories that generated and shared SARS-CoV-2 viral genomes via the GISAID Initiative, on which this research is based.